Boston-based Dana-Farber Cancer Institute and Brigham and Women’s Hospital were designated as a Pheo Para Clinical Center June 28 for patients with rare neuroendocrine tumors.
Read the full post on Becker's Hospital Review - Healthcare News
Dana-Farber Cancer Institute, Brigham and Women”s Hospital designated as rare disease clinical center
